Yi Larson - 01 Dec 2021 Form 4 Insider Report for LianBio (LIANY)

Role
Chief Financial Officer
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Dec 2021, 15:05:10 UTC
Previous filing
01 Nov 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Award $0 +5,996 +0.5% $0.000000 1,202,841 01 Dec 2021 Ordinary Shares 5,996 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest and become exercisable on December 1, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.